Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients

Completed · Phase 3

Conditions studied: HIV

In brief

The purpose of this study is to describe the safety, efficacy, and pharmacokinetics of a regimen of atazanavir powder boosted with ritonavir and an optimized dual nucleoside reverse transcriptase inhibitor in pediatric patients aged ≥3 months to \<11 years.

Key facts

Study ID
NCT01335698
Run by
Bristol-Myers Squibb
People needed
160
Starts
2011-05-27
Expected to finish
2018-01-22
Last updated by the study team
2018-11-09

Who can join

Age: 0 and older, up to 11. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.